logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5115.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5115.produseast1
Conference Material
|Slide Presentation

Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis

Nyang'wa BT, Berry C, Motta I, Kazounis E
Download
Similar Content
Video
|Video
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis
2021 May 19 • MSF Scientific Days International 2021 Research
Abstract
|Abstract
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis
2021 May 19 • MSF Scientific Days International 2021 Research
Loading...
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis | Conference Material / Slide Presentation | MSF Science Portal

Countries

Belarus South Africa Uzbekistan

Subject Area

antibiotic resistancetuberculosisantimicrobial resistance

Languages

English
Published Date
19 May 2021
Conference
MSF Scientific Days International 2021: Research
Linked Content
Conference Material
|Video
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis
2021 May 19 • MSF Scientific Days International 2021 Research
Conference Material
|Abstract
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis
2021 May 19 • MSF Scientific Days International 2021 Research